Indication

Weight loss management for obese patient (body mass index 30 or greater)

This indication designates chronic clinical intervention for adult patients diagnosed with obesity, defined as having a body mass index of 30 kg/m² or greater. Read more about Weight loss management for obese patient (body mass index 30 or greater)

106 drugs 60 manufacturers

Advertisement

Drugs that treat it

Common Weight loss management for obese patient (body mass index 30 or greater) therapies.

Showing 46–54 of 106 drugs

PHENTERMINE HCL

AMPHETAMINES/ANOREXIANTS/STIMULANTS·WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)·+1
SUNRISE PHARMAC

PHENTERMINE HCL

AMPHETAMINES/ANOREXIANTS/STIMULANTS·WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)·+1
SOLCO HEALTHCAR

XENICAL (orlistat)

FAT ABSORPTION DECREASING AGENTS·WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)
H2 PHARMA LLC

BENZPHETAMINE HCL

WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER)
PAR HEALTH USA,

AMPHETAMINE SULFATE

AMPHETAMINES/ANOREXIANTS/STIMULANTS·ATTENTION-DEFICIT HYPERACTIVITY DISORDER·+2
WILSHIRE PHARMA
Filter & compare in the drug finder →Opens the drug finder with Weight loss management for obese patient (body mass index 30 or greater) preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Weight loss management for obese patient (body mass index 30 or greater).

This indication designates chronic clinical intervention for adult patients diagnosed with obesity, defined as having a body mass index of 30 kg/m² or greater.

Obesity is a complex, multifactorial, relapsing chronic metabolic disease characterized by excessive adiposity resulting from sustained energy imbalance.

This pathological accumulation of adipose tissue induces systemic neuroendocrine dysfunction, adipokine dysregulation, and persistent low-grade inflammation.

Left unmanaged, it significantly impairs multiple organ systems and increases the risk of chronic comorbidities, including atherosclerotic cardiovascular disease, hypertension, type 2 diabetes mellitus, dyslipidemia, and obstructive sleep apnea.

Personalize your experience

Follow Weight loss management for obese patient (body mass index 30 or greater) and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it